Enanta Pharmaceuticals (ENTA) Current Taxes (2014 - 2018)

Enanta Pharmaceuticals has reported Current Taxes for 5 years, with the latest figure at $5.9 million in Q4 2018.

• For the quarter ending Q4 2018, Current Taxes fell 42.89% year-over-year to $5.9 million; the trailing twelve-month figure through Dec 2018 stood at $5.9 million (down 42.89% YoY), and the FY2018 full-year result was $1.4 million, down 85.07% from the prior year.
• Current Taxes for Q4 2018 stood at $5.9 million, up from $1.4 million in the prior quarter.
• The five-year high for Current Taxes was $16.9 million in Q4 2014, with the low at $1.2 million in Q3 2015.
• Historically, Current Taxes has averaged $6.8 million across 5 years, with a median of $5.6 million in 2018.
• Annual changes were most pronounced in 2016 — Current Taxes soared 31.99% — and 2018, when it plunged 85.07%.
• Enanta Pharmaceuticals' Current Taxes stood at $16.9 million in 2014, then slumped by 70.76% to $4.9 million in 2015, then slumped by 40.45% to $2.9 million in 2016, then soared by 248.64% to $10.3 million in 2017, then plunged by 42.89% to $5.9 million in 2018.
• The last three Current Taxes figures came in at $5.9 million (Q4 2018), $1.4 million (Q3 2018), and $5.4 million (Q1 2018), per Business Quant data.